Clinical Trial Update: Retlirafusp Alfa Injection Combined Chemotherapy for Perioperative Treatment of Esophagogastric Junction Adenocarcinoma: A Single-Arm, Phase II Study of Safety and Efficacy [NA]

View source ↗

Summary

This is a single-arm Phase II study assessing the safety and efficacy of Retlirafusp Alfa in combination with chemotherapy as perioperative treatment for esopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Adenocarcinoma

Drugs mentioned

• Retlirafusp Alfa (retlirafusp alfa)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: GEJ Adenocarcinoma | NA | Status: NOT_YET_RECRUITING